(S)-3-Hydroxybutanoic acid, 95.0%, 100mg

Ethyl 2-(2-(trifluoromethyl)pyrimidin-5-yl)acetate, 98%, 10g

Thalidomide-NH-C4-NH-Boc, 50mg

(2S,4R)-4-(Benzyloxy)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 95.0%, 25g

Peso di calibrazione Classe OIML M1 Senza certificato, 500 g

8-Amino-3,6-dioxaoctanoic acid tert-butyl ester, 97.0%, 250mg

1-Bromo-3-methylbutane>96.0%(GC)25g

3-Methyl-4-heptanone>95.0%(GC)10mL

(4R,4'R)-2,2'-[2-PHENYL-1-(PHENYLMETHYL)ETHYLIDENE]BIS[4-(1-METHYLETHYL)-4,5-DIHYDROOXAZOLE, 95%, 5g

N~2~-methyl-N~2~-phenyl-1,2-propanediamine hydrochloride, 95.0%, 1g

(S)-2,2-Dimethylcyclopropanecarboxylic acid, 95.0%, 250mg

Sacchetto per omogeneizzazione Whirl-Pak® con area di etichettatura, 1650 ml, 190 mm, Altezza, 300 mm, 500 Pezzo(i)

[(2,2,2-trifluoroethyl)thio]-benzene, 99.0%, 250mg